Baylis Medical Technologies

What Baylis Medical Technologies does

Baylis Medical Technologies is a privately held medical device company headquartered in Mississauga, Ontario, Canada, with a US sales office in Fort Worth, Texas. The company traces its origins to 1986, when Gloria Baylis founded Baylis Medical Company; the current entity was spun off in 2022 ahead of Boston Scientific's $1.75B USD acquisition of the predecessor company, retaining the Endovascular and Design and Manufacturing Services divisions. It employs 51–100 people and operates from a headquarters plus adjacent manufacturing facility in Mississauga, with a US subsidiary (Baylis Medical Technologies USA Inc.) in Fort Worth. The company develops, produces, and distributes radiofrequency (RF) puncture systems for endovascular interventions, anchored by the PowerWire RF Guidewire family — PowerWire Pro (510(k) cleared March 2024), PowerWire Pulse (commercially launched October 2024), and PowerWire 14 (510(k) cleared April 2026, the first 0.014-inch RF-enabled crossing wire) — all of which use controlled RF energy with automatic termination upon metal contact to cross totally occluded peripheral vessels, including stented vessels 3mm or greater.

The portfolio is completed by the Passport Steerable Sheath and Destino Steerable Sheath family (Twist and Reach variants), the RFP-100A RF Puncture Generator capital equipment, the Nykanen RF Wire, and the ProTrack Microcatheter. The company sells primarily through enterprise field sales directly to US hospitals and healthcare facilities, with a secondary channel through an Oscor (an Integer company) distribution partnership for steerable and guiding sheaths. Pricing is quote-based and not publicly disclosed. Target customers are interventional radiologists and vascular surgeons, with a secondary use case in dialysis access / nephrology for central venous recanalization. The Design and Manufacturing Services division provides contract manufacturing to other medical device companies. Laura Conquergood, formerly VP of Access Solutions at Boston Scientific, was appointed CEO in June 2025 with a stated mandate for international growth, while co-founders Kris Shah and Frank Baylis serve as Co-Executive Chairmen.

Name

Baylis Medical Technologies

Legal name

Baylis Medical Technologies Inc.

Website

https://baylismedtech.com

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

51–100 employees

Short description

Baylis Medical Technologies is a privately held medical device company that develops and sells radiofrequency (RF) puncture systems — led by its PowerWire guidewire family — to hospitals and interventional radiology and vascular surgery specialists for crossing totally occluded peripheral vessels.

Ownership category

akta.pro rank

Product category

Endovascular Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems) (HLAHAFAK)

akta.pro secondary industry

Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG)

Keywords

• Endovascular medical devices
• Radiofrequency guidewires
• Interventional radiology
• Steerable sheaths
• Vascular surgery equipment

Headquarters

HQ city

Mississauga

HQ country

Canada

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Baylis Medical Technologies generates revenue through the sale of proprietary medical devices including RF guidewires (PowerWire family), steerable sheaths, and capital equipment (RFP-100A RF Generator). Products are sold directly to hospitals and healthcare professionals in interventional radiology and vascular surgery specialties. The company also provides contract manufacturing services to other medical device companies through its Design and Manufacturing Services division.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Baylis Medical Technologies develops, manufactures, and commercializes radiofrequency (RF)-enabled medical devices for endovascular interventions. Its core offerings include the PowerWire family of RF guidewires (Pro, 14, and Pulse variants) used to cross totally occluded peripheral vessels, the Passport and Destino steerable sheath product lines, the RFP-100A RF Puncture Generator as capital equipment, and supplementary devices such as the Nykanen RF Wire and ProTrack Microcatheter. Products are sold directly to hospitals and interventional radiology and vascular surgery professionals, complemented by a Design and Manufacturing Services division that provides contract manufacturing.

Product overview

Baylis Medical Technologies offers a portfolio of radiofrequency (RF) medical devices primarily for endovascular interventions. The core product family includes the PowerWire® RF Guidewire series (Pro, 14, and Pulse variants) that utilize RF energy to cross chronically occluded peripheral vessels including stented vessels. Supporting products include the Passport® and Destino™ steerable sheath lines for vascular access navigation, the RFP-100A RF Puncture Generator as capital equipment, the Nykanen RF Wire, and the ProTrack Microcatheter. The company operates through divisions of Endovascular (clinical solutions) and Design and Manufacturing Services (contract manufacturing), serving healthcare professionals worldwide to improve patient outcomes in cardiovascular and other medical conditions.

Differentiator

Problem solved

Functional benefit

Brands

• PowerWire: Family of RF Guidewire products including PowerWire Pro, PowerWire Pulse, and PowerWire 14 for radiofrequency-assisted crossing of occluded vessels.
• Passport
• Sniper Technique
• Gloria Baylis Foundation
• Shah Family Foundation

Products and services

• PowerWire Pro RF Guidewire Radiofrequency (RF) guidewire designed to cross totally occluded peripheral vessels 3mm or greater, including those with stents. Features selective RF energy application with automatic termination when contacting metal to reduce vessel extravasation risk during in-stent crossing.
• PowerWire 14 RF Guidewire The first 0.014-inch RF-enabled crossing wire for navigating challenging occlusions. Combines RF-assisted crossing capability with a smaller profile for use in complex anatomies and high-pressure systems where precision and controlled advancement are critical.
• PowerWire Pulse RF Guidewire 0.035-inch RF guidewire designed to create a path through soft tissues with controlled RF puncture technology. Features a torquable stiff proximal shaft for optimal control with smooth transition to a flexible distal end.
• Passport Steerable Sheath Steerable sheath designed to navigate the vascular system with control and precision. Enables access to target sites in complex endovascular procedures.
• Nykanen RF Wire RF wire kit for radiofrequency puncture procedures. Part of the RF wire portfolio for endovascular interventions.
• Destino Steerable Sheath Steerable sheath offering precise navigation for endovascular procedures.
• Destino Twist Steerable Sheath Twist variant of the Destino steerable sheath with enhanced navigation capabilities.
• Destino Reach Steerable Sheath Extended reach variant of the Destino steerable sheath for challenging anatomies.
• RFP-100A RF Puncture Generator RF generator that powers the PowerWire RF guidewire family for radiofrequency-assisted vessel crossing procedures.
• ProTrack Microcatheter Microcatheter used to support endovascular procedures, available through the company's product portfolio.

Named customers1 record

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• OscorcoreChannel Partner/ Reseller/ Distributor · 27 October 2022Baylis Medical Technologies formed a distribution partnership with Oscor (an Integer company) in October 2022, assuming responsibility for sales and distribution of Oscor's steerable and guiding sheaths directly to hospitals in the United States. This partnership expanded Baylis's vascular footprint and complemented its existing product offerings including the PowerWire RF guidewire family. The companies worked closely together to ensure minimal customer impact during the business transition.

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Penumbra, Inc. Penumbra develops endovascular and neurovascular devices including aspiration and mechanical thrombectomy systems. Both companies target interventional radiology and vascular surgery accounts with proprietary access and crossing tools, making Penumbra the most directly comparable independent peer.
• Inari Medical (Stryker): Specialist in venous-specific interventional devices, including FlowTriever and ClotTriever systems. Targets the same interventional radiology and vascular surgery call points as Baylis, with overlapping procedural focus on complex venous occlusions.
• Silk Road Medical: Developer of the ENROUTE Transcarotid Neuroprotection System and other carotid/vascular access tools. Comparable in targeting complex endovascular procedures through specialized access platforms and selling into similar specialist accounts.
• AngioDynamics: Mid-cap medical device company with peripheral vascular and oncology franchises including angiographic catheters and ablation technologies. Comparable in scale and customer focus on interventional radiology and vascular surgery.

Broad incumbents

• Boston Scientific: Global medtech incumbent and acquirer of the original Baylis Medical Company for $1.75B in 2022. Overlapping endovascular and vascular access franchises make Boston Scientific both a former parent and a direct competitor in interventional cardiology and peripheral vascular.
• Abbott Vascular: Division of Abbott offering a broad guidewire, sheath, and crossing portfolio for peripheral and coronary interventions. Competes with Baylis in vascular access and chronic total occlusion procedures through products like the NaviCross and Hi-Torque wire families.
• Medtronic: Diversified medtech incumbent that acquired Baylis's OsteoCool bone tumor ablation business in 2016. Operates large peripheral vascular, endovascular, and vascular access franchises that overlap with Baylis PowerWire and sheath portfolios.
• Teleflex: Medical device manufacturer with a meaningful vascular access and interventional franchise (Arrow, Guidewire, Sheath portfolios). Comparable customer base in interventional radiology and vascular surgery and overlapping product categories with Baylis.
• Cardiovascular Systems, Inc. (Abbott): Acquired by Abbott in 2023, CSI developed orbital atherectomy systems for peripheral and coronary interventions. Direct competitor in complex peripheral vascular interventions alongside Baylis PowerWire RF crossing technology.

Others

• Integer Holdings (Oscor): Parent of Oscor, the distribution partner supplying Passport and Destino steerable sheaths to Baylis. Closely adjacent as both a partner and a competing medical device manufacturer in steerable sheaths and access products.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/BaylisMedTech
• YouTubeyoutube.com/@baylismedtech
• LinkedInlinkedin.com/company/baylismedtech
• Instagraminstagram.com/baylismedtech?igshid=MzRlODBiNWFlZA==

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Baylis Medical Technologies